GeneDx Holdings Corp. updated earnings guidance for the year 2024. For the year, the company now expects revenues to be between $235 million and $245 million (previous guidance was $220 million to $230 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.75 USD | -4.64% | -2.81% | +654.55% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+654.55% | 569M | |
-23.00% | 8.54B | |
+67.47% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-8.65% | 1.9B | |
-17.46% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Updates Earnings Guidance for the Year 2024